Search research articles
Contact Us
Filters
Showing results (101-110 of 369) with videos related to
Page
of 37
Sort By:
Bailliere'S Best Practice & Research. Clinical Obstetrics & Gynaecology
|
January 6, 2001
Angiogenesis in ovarian cancer
M R Brown, J O Blanchette, E C Kohn
Experimental Cell Research
|
July 10, 1997
Regulation of cellular tyrosine phosphorylation by stimulatory and inhibitory muscarinic acetylcholine receptors
R Alessandro, A Pugnaloni, G Biagini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 15, 2013
PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies
J-M Lee, J A Ledermann, E C Kohn
Cancer
|
December 15, 2023
Top advances of the year: Ovarian cancer
Melissa A Lumish, Elise C Kohn, William P Tew
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 2, 2016
Gynecologic Cancers: Emerging Novel Strategies for Targeting DNA Repair Deficiency
Rebecca S Kristeleit, Rowan E Miller, Elise C Kohn
Trends in Cancer
|
July 26, 2017
The 'Pushmi-Pullyu' of DNA REPAIR: Clinical Synthetic Lethality
S Percy Ivy, Johann de Bono, Elise C Kohn
Cancer Research
|
June 1, 1992
In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates
E C Kohn, M A Sandeen, L A Liotta
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice
|
June 15, 2005
Applying proteomics in clinical trials: assessing the potential and practical limitations in ovarian cancer
Nana E Tchabo, Meghan S Liel, Elise C Kohn
JAMA
|
November 17, 2001
Clinical proteomics: personalized molecular medicine
L A Liotta, E C Kohn, E F Petricoin
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
December 1, 1994
The importance of biological realism in dioxin risk assessment models
M C Kohn, G W Lucier, C J Portier
Page
of 37
Search research articles
Search
Showing results (101-110 of 369) with videos related to
Sort By:
Page
of 37
Bailliere'S Best Practice & Research. Clinical Obstetrics & Gynaecology
|
January 6, 2001
Angiogenesis in ovarian cancer
M R Brown, J O Blanchette, E C Kohn
Experimental Cell Research
|
July 10, 1997
Regulation of cellular tyrosine phosphorylation by stimulatory and inhibitory muscarinic acetylcholine receptors
R Alessandro, A Pugnaloni, G Biagini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 15, 2013
PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies
J-M Lee, J A Ledermann, E C Kohn
Cancer
|
December 15, 2023
Top advances of the year: Ovarian cancer
Melissa A Lumish, Elise C Kohn, William P Tew
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 2, 2016
Gynecologic Cancers: Emerging Novel Strategies for Targeting DNA Repair Deficiency
Rebecca S Kristeleit, Rowan E Miller, Elise C Kohn
Trends in Cancer
|
July 26, 2017
The 'Pushmi-Pullyu' of DNA REPAIR: Clinical Synthetic Lethality
S Percy Ivy, Johann de Bono, Elise C Kohn
Cancer Research
|
June 1, 1992
In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates
E C Kohn, M A Sandeen, L A Liotta
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice
|
June 15, 2005
Applying proteomics in clinical trials: assessing the potential and practical limitations in ovarian cancer
Nana E Tchabo, Meghan S Liel, Elise C Kohn
JAMA
|
November 17, 2001
Clinical proteomics: personalized molecular medicine
L A Liotta, E C Kohn, E F Petricoin
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
December 1, 1994
The importance of biological realism in dioxin risk assessment models
M C Kohn, G W Lucier, C J Portier
Page
of 37